Multiple Endocrine Neoplasia Type 1

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 2, Issue , 2010, Pages 2719-2741

  Thakker, Rajesh V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85153832779     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00150-7     Document Type: Chapter

References (328)

1. RV Thakker and BA Ponder (1988) Multiple endocrine neoplasia. Baillieres Clin Endocrinol Metab 2 1031-1067.
2. R Thakker (1995) Multiple endocrine neoplasia type 1 (MEN1). LJ DeGroot, M Besser, HG Burger, et al., (Eds) Endocrinology ed 3 Philadelphia: WB Saunders 2815-2831.
3. SJ Marx (1998) Multiple endocrine neoplasia type 1. B Vogelstein,(Eds) Genetic Basis of Human Cancer New York: McGraw-Hill 489-506.
4. LO Underdahl, LB Woolner and BM Black (1953) Multiple endocrine adenomas: report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. J Clin Endocrinol Metab 13 20-47.
5. CC Berdjis (1962) Pluriglandular syndrome, II: Multiple endocrine adenomas in man: a report of five cases and a review of literature. Ophthalmologica 15 288-311.
6. AL Steiner, AD Goodman and SR Powers (1968) Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: Multiple endocrine neoplasia, type 2. Medicine (Baltimore) 47 371-409.
7. P Wermer (1974) Multiple endocrine adenomatosis: Multiple hormone-producing tumors, a familial syndrome. Clin Gastroenterol 3 671-684.
8. P Wermer (1954) Genetic aspects of adenomatosis of endocrine glands. Am J Med 16 363-371.
9. D Trump, B Farren, C Wooding, et al. (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89 653-669.
10. J Sipple (1961) The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31 163-166.
11. BA Ponder (1998) Clinical expressions of multiple endocrine neoplasia type 2. B Vogelstein,(Eds) The Genetic Basis of Human Cancer New York: McGraw-Hill 486-487.
12. RF Gagel and GS Cote (2002) The role of the Ret protooncogene in multiple endocrine neoplasia type 2. JP Bilezikian, LG Raisz, GA Rodan,(Eds) Principles of bone biology San Diego: Academic Press 1067-1078.
13. RN Schimke (1990) Multiple endocrine neoplasia: How many syndromes? Am J Med Genet 37 375-383.
14. R Tateishi, A Wada, S Ishiguro, et al. (1978) Coexistence of bilateral pheochromocytoma and pancreatic islet cell tumor: Report of a case and review of the literature. Cancer 42 2928-2934.
15. JA Carney, VL Go, H Gordon, et al. (1980) Familial pheochromocytoma and islet cell tumor of the pancreas. Am J Med 68 515-521.
16. JR Zeller, HM Kauffman, RA Komorowski, et al. (1982) Bilateral pheochromocytoma and islet cell adenoma of the pancreas. Arch Surg 117 827-830.
17. MT Kahn and DA Mullon (1964) Pheochromocytoma without hypertension: Report of a patient with acromegaly. JAMA 188 74-75.
18. GL Miller and J Wynn (1971) Acromegaly, pheochromocytoma, toxic goiter, diabetes mellitus, and endometriosis. Arch Intern Med 127 299-303.
19. V McKusick (1998) Mendelian Inheritance in Man. Baltimore: Johns Hopkins University Press
20. RV Thakker (1998) Multiple endocrine neoplasia: Syndromes of the twentieth century. J Clin Endocrinol Metab 83 2617-2620.
21. J Erdheim (1903) Zur normalen und pathologischen histologie der glandular thyreoidea, und hypophysis. Beitr Pathol Anat 33 158-236.
22. H Cushing (1927) The Pathological Findings in Four Autopsied Cases of Acromegaly with a Discussion of Their Significance. New York: Rockefeller Institute of Medicine Research Monograph
23. P Lloyd (1929) A case of hypophyseal tumor with associated tumor-like enlargement of the parathyroids and islands of Langerhans. Bull Johns Hopkins Hosp 45 1-14.
24. P Rossier (1939) Familiare erkrankung innersekretorischer Drusen kombiniert mit ulkuskrankheit. Schweiz Med Wochenschr 69 985-990.
25. MP Moldawer (1953) Case records of the Massachusetts General Hospital, case 39501. N Engl J Med 249 990-993.
26. MP Moldawer, GL Nardi and JW Raker (1954) Concomitance of multiple adenomas of the parathyroids and pancreatic islets with tumor of the pituitary: A syndrome with a familial incidence. Am J Med Sci 228 190-206.
27. HS Ballard, B Fame and RJ Hartsock (1964) Familial multiple endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 43 481-516.
28. AG Pearse (1968) Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin. Proc R Soc Lond B Biol Sci 170 71-80.
29. AG Pearse (1969) The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 17 303-313.
30. NM Le Douarin (1982) Developmental relationship between the neural crest and the polypeptide-hormone secreting cells. The Neural Crest London: Cambridge University Press 91-107.
31. RL Pictet, LB Rall, P Phelps, et al. (1976) The neural crest and the origin of the insulin-producing and other gastrointestinal hormone-producing cells. Science 191 191-192.
32. NM Le Douarin and MA Teillet (1973) The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morphol 30 31-48.
33. RF Weichert 3rd (1970) The neural ectodermal origin of the peptide-secreting endocrine glands: A unifying concept for the etiology of multiple endocrine adenomatosis and the inappropriate secretion of peptide hormones by nonendocrine tumors. Am J Med 49 232-241.
34. RV Thakker (1993) The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol (Oxf) 38 1-14.
35. HE Varmus (1984) The molecular genetics of cellular oncogenes. Annu Rev Genet 18 553-612.
36. SH Friend, TP Dryja and RA Weinberg (1988) Oncogenes and tumor-suppressing genes. N Engl J Med 318 618-622.
37. ER Fearon (1997) Human cancer syndromes: Clues to the origin and nature of cancer. Science 278 1043-1050.
38. C Larsson, B Skogseid, K Oberg, et al. (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332 85-87.
39. E Friedman, K Sakaguchi, AE Bale, et al. (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321 213-218.
40. RV Thakker, P Bouloux, C Wooding, et al. (1989) Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321 218-224.
41. FS Collins (1992) Positional cloning: Let's not call it reverse anymore. Nat Genet 1 3-6.
42. SC Chandrasekharappa, SC Guru, P Manickam, et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 404-407.
43. The European Consortium on MEN1 (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 6 1177-1183.
44. SK Agarwal, SC Guru, C Heppner, et al. (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96 143-152.
45. PD Leotlela, A Jauch, H Holtgreve-Grez, et al. (2003) Genetics of neuroendocrine and carcinoid tumors. Endocr Relat Cancer 10 437-450.
46. CJ Lips, HF Vasen and CB Lamers (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2 117-184.
47. ML Brandi, SJ Marx, GD Aurbach, et al. (1987) Familial multiple endocrine neoplasia type I: A new look at pathophysiology. Endocr Rev 8 391-405.
48. T Christensson (1976) Familial hyperparathyroidism. Ann Intern Med 85 614-615.
49. CE Jackson and CE Boonstra (1967) The relationship of hereditary hyperparathyroidism to endocrine adenomatosis. Am J Med 43 727-734.
50. S Uchino, S Noguchi, M Sato, et al. (2000) Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60 5553-5557.
51. L Bardram and JG Stage (1985) Frequency of endocrine disorders in patients with the Zollinger-Ellison syndrome. Scand J Gastroenterol 20 233-238.
52. DR Farley, JA van Heerden, CS Grant, et al. (1992) The Zollinger-Ellison syndrome: A collective surgical experience. Ann Surg 215 561-569.
53. BW Scheithauer, ER Laws Jr, K Kovacs, et al. (1987) Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 4 205-211.
54. L Schaaf, M Greschner, W Geissler, et al. (1990) The importance of multiple endocrine neoplasia syndromes in differential diagnosis. Klin Wochenschr 68 669-672.
55. S Corbetta, A Pizzocaro, M Peracchi, et al. (1997) Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumors of different types. Clin Endocrinol (Oxf) 47 507-512.
56. SE Carty, AK Helm, JA Amico, et al. (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124 1106-1113.
57. AL Gelston, MB Delisle and YC Patel (1982) Multiple endocrine adenomatosis type I: Occurrence in an octogenarian with high levels of circulating pancreatic polypeptide. JAMA 247 665-666.
58. JJ Shepherd (1985) Latent familial multiple endocrine neoplasia in Tasmania. Med J Aust 142 395-397.
59. SJ Marx, AI Vinik, RJ Santen, et al. (1986) Multiple endocrine neoplasia type I: Assessment of laboratory tests to screen for the gene in a large kindred. Medicine (Baltimore) 65 226-241.
60. L Benson, S Ljunghall, G Akerstrom, et al. (1987) Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med 82 731-737.
61. HF Vasen, CB Lamers and CJ Lips (1989) Screening for the multiple endocrine neoplasia syndrome type I: a study of 11 kindreds in The Netherlands. Arch Intern Med 149 2717-2722.
62. ML Brandi, RF Gagel, A Angeli, et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86 5658-5671.
63. RS Bahn, BW Scheithauer, JA van Heerden, et al. (1986) Nonidentical expressions of multiple endocrine neoplasia, type I, in identical twins. Mayo Clin Proc 61 689-696.
64. DE Flanagan, M Armitage, GP Clein, et al. (1996) Prolactinoma presenting in identical twins with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 45 117-120.
65. P Concolino, A Rossodivita, C Carrozza, et al. (2008) A novel MEN1 frameshift germline mutation in two Italian monozygotic twins. Clin Chem Lab Med 46 824-826.
66. JH Bassett, SA Forbes, AA Pannett, et al. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 62 232-244.
67. S Wilkinson, BT Teh, KR Davey, et al. (1993) Cause of death in multiple endocrine neoplasia type 1. Arch Surg 128 683-690.
68. GM Doherty, JA Olson, MM Frisella, et al. (1998) Lethality of multiple endocrine neoplasia type I. World J Surg 22 581-586.
69. JR Burgess, TM Greenaway and JJ Shepherd (1998) Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 243 465-470.
70. PG Dean, JA van Heerden, DR Farley, et al. (2000) Are patients with multiple endocrine neoplasia type I prone to premature death? World J Surg 24 1437-1441.
71. JT Majewski and SD Wilson (1979) The MEA-I syndrome: an all or none phenomenon? Surgery 86 475-484.
72. F Eberle and R Grun (1981) Multiple endocrine neoplasia, type I (MEN I). Ergeb Inn Med Kinderheilkd 46 76-149.
73. F Gibril, M Schumann, A Pace, et al. (2004) Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83 43-83.
74. SJ Marx, AM Spiegel, MA Levine, et al. (1982) Familial hypocalciuric hypercalcemia: The relation to primary parathyroid hyperplasia. N Engl J Med 307 416-426.
75. A Agha, R Carpenter, S Bhattacharya, et al. (2007) Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J Endocrinol Invest 30 145-149.
76. JC Croisier, E Azerad and J Lubetzki (1971) Polyendocrine adenomatosis (Wermer's syndrome) Apropos of a personal case: review of the literature. Sem Hop 47 494-525.
77. CB Lamers and PG Froeling (1979) Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I). Am J Med 66 422-424.
78. JL Kraimps, QY Duh, M Demeure, et al. (1992) Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 112 1080-1086.
79. P Hellman, B Skogseid, C Juhlin, et al. (1992) Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1. World J Surg 16 718-722.
80. JA van Heerden, RB Kent 3rd, GW Sizemore, et al. (1983) Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes: Surgical experience. Arch Surg 118 533-536.
81. WC Black 3rd and JR Utley (1968) The differential diagnosis of parathyroid adenoma and chief cell hyperplasia. Am J Clin Pathol 49 761-775.
82. R Rizzoli, J Green 3rd and SJ Marx (1985) Primary hyperparathyroidism in familial multiple endocrine neoplasia type I: long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med 78 467-474.
83. RA Prinz, OI Gamvros, D Sellu, et al. (1981) Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type I syndrome. Ann Surg 193 26-29.
84. LA Lambert, SE Shapiro, JE Lee, et al. (2005) Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 140 374-382.
85. JA Norton, DJ Venzon, MJ Berna, et al. (2008) Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg 247 501-510.
86. C Rudberg, G Akerstrom, M Palmer, et al. (1986) Late results of operation for primary hyperparathyroidism in 441 patients. Surgery 99 643-651.
87. SA Wells Jr, GJ Ellis, JC Gunnells, et al. (1976) Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med 295 57-62.
88. SA Wells Jr, JR Farndon, JK Dale, et al. (1980) Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg 192 451-458.
89. AW Saxe and MF Brennan (1982) Reoperative parathyroid surgery for primary hyperparathyroidism caused by multiple-gland disease: Total parathyroidectomy and autotransplantation with cryopreserved tissue. Surgery 91 616-621.
90. LE Mallette, T Blevins, PH Jordan, et al. (1987) Autogenous parathyroid grafts for generalized primary parathyroid hyperplasia: Contrasting outcome in sporadic hyperplasia versus multiple endocrine neoplasia type I. Surgery 101 738-745.
91. D Grama, B Skogseid, E Wilander, et al. (1992) Pancreatic tumors in multiple endocrine neoplasia type 1: Clinical presentation and surgical treatment. World J Surg 16 611-618.
92. RM Zollinger and EH Ellison (1955) Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142 709-723.
93. RA Gregory, MI Grossman, HJ Tracy, et al. (1967) Nature of the gastric secretagogue in Zollinger-Ellison tumors. Lancet 2 543-544.
94. RA Gregory, HJ Tracy, JM French, et al. (1960) Extraction of a gastrin-like substance from a pancreatic tumor in a case of Zollinger-Ellison syndrome. Lancet 1 1045-1048.
95. D Metz (1994) Multiple endocrine neoplasia type 1: clinical features and management. JP Bilezikian,(Eds) The Parathyroids New York: Raven 591-636.
96. M Pipeleers-Marichal, G Somers, G Willems, et al. (1990) Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 322 723-727.
97. F Yu, DJ Venzon, J Serrano, et al. (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 17 615-630.
98. CM Townsend Jr and JC Thompson (1990) Gastrinoma. Semin Surg Oncol 6 91-97.
99. JK Lowney, MM Frisella, TC Lairmore, et al. (1998) Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery 124 1043-1048.
100. MM Wolfe and RT Jensen (1987) Zollinger-Ellison syndrome: current concepts in diagnosis and management. N Engl J Med 317 1200-1209.
101. B Wiedenmann, RT Jensen, M Mignon, et al. (1998) Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg 22 309-318.
102. JB Betts, BP O'Malley and FD Rosenthal (1980) Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis type 1: Report of a further family and a review of the literature. Q J Med 49 69-76.
103. MH Thompson, DJ Sanders and ER Grund (1976) The relationship of the serum gastrin and calcium concentrations in patients with multiple endocrine neoplasia type I. Br J Surg 63 779-783.
104. KE McArthur, MJ Collen, PN Maton, et al. (1985) Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome. Gastroenterology 88 939-944.
105. RT Jensen (1998) Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 243 477-488.
106. CW Deveney, S Stein and LW Way (1983) Cimetidine in the treatment of Zollinger-Ellison syndrome. Am J Surg 146 116-123.
107. RT Jensen, MJ Collen, KE McArthur, et al. (1984) Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. Am J Med 77 90-105.
108. NW Thompson (1998) Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1. Surg Oncol Clin North Am 7 881-891.
109. B Skogseid, K Oberg, B Eriksson, et al. (1996) Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 20 872-876.
110. G Cadiot, A Vuagnat, I Doukhan, et al. (1999) Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1: Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 116 286-293.
111. YN You, GB Thompson, WF Young Jr, et al. (2007) Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. Surgery 142 829-836.
112. JA Norton, DL Fraker, HR Alexander, et al. (1999) Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341 635-644.
113. MA Kouvaraki, SE Shapiro, GJ Cote, et al. (2006) Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg 30 643-653.
114. R Delcore Jr, AS Hermreck and SR Friesen (1989) Selective surgical management of correctable hypergastrinemia. Surgery 106 1094-1100.
115. BC Sheppard, JA Norton, JL Doppman, et al. (1989) Management of islet cell tumors in patients with multiple endocrine neoplasia: A prospective study. Surgery 106 1108-1117.
116. P Ruszniewski, P Podevin, G Cadiot, et al. (1993) Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas 8 295-304.
117. NW Thompson, AG Bondeson, L Bondeson, et al. (1989) The surgical treatment of gastrinoma in MEN I syndrome patients. Surgery 106 1081-1085.
118. SR Wise, J Johnson, J Sparks, et al. (1989) Gastrinoma: The predictive value of preoperative localization. Surgery 106 1087-1092.
119. B Termanini, F Gibril, JC Reynolds, et al. (1997) Value of somatostatin receptor scintigraphy: A prospective study in gastrinoma of its effect on clinical management. Gastroenterology 112 335-347.
120. G Cadiot, R Lebtahi, L Sarda, et al. (1996) Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy: Groupe d'Etude Du Syndrome De Zollinger-Ellison. Gastroenterology 111 845-854.
121. R Bansal, W Tierney, S Carpenter, et al. (1999) Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 49 19-25.
122. JJ Turner, AM Wren, JE Jackson, et al. (2002) Localization of gastrinomas by selective intra-arterial calcium injection. Clin Endocrinol (Oxf) 57 821-825.
123. JA Norton and RT Jensen (2007) Role of surgery in Zollinger-Ellison syndrome. J Am Coll Surg 205 534-537.
124. CG Moertel, JA Hanley and LA Johnson (1980) Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med 303 1189-1194.
125. LK Kvols, M Buck, CG Moertel, et al. (1987) Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med 107 162-168.
126. CH Carrasco, VP Chuang and S Wallace (1983) Apudomas metastatic to the liver: treatment by hepatic artery embolization. Radiology 149 79-83.
127. B Eriksson, K Oberg, G Alm, et al. (1986) Treatment of malignant endocrine pancreatic tumors with human leucocyte interferon. Lancet 2 1307-1309.
128. JA Norton, JL Doppman, MJ Collen, et al. (1986) Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg 204 468-479.
129. JC Croisier, T Lehy and P Zeitoun (1971) A2 cell pancreatic microadenomas in a case of multiple endocrine adenomatosis. Cancer 28 707-713.
130. JT Peurifoy, LG Gomez and JC Thompson (1979) Separate pancreatic gastrin cell and beta-cell adenomas: Report of a patient with multiple endocrine adenomatosis type 1. Arch Surg 114 956-958.
131. RC Eastman (1990) Hypoglycemia. W Moore,(Eds) Diagnostic Endocrinology Toronto: BC Decker 183-191.
132. MJ Demeure, DC Klonoff, JH Karam, et al. (1991) Insulinomas associated with multiple endocrine neoplasia type I: The need for a different surgical approach. Surgery 110 998-1004.
133. JL Doppman, DL Miller, R Chang, et al. (1991) Insulinomas: Localization with selective intraarterial injection of calcium. Radiology 178 237-241.
134. GM Doherty, JL Doppman, TH Shawker, et al. (1991) Results of a prospective strategy to diagnose, localize, and resect insulinomas. Surgery 110 989-996.
135. CS Grant, J van Heerden, JW Charboneau, et al. (1988) The value of intraoperative ultrasonography. Arch Surg 123 843-848.
136. D O'Shea, AW Rohrer-Theurs, JA Lynn, et al. (1996) Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab 81 1623-1627.
137. L Broder (1974) Chemotherapy of malignant insulinomas with streptozotocin, Proc 8th Intl Congr. Diabetes 314 714-727.
138. JR Burgess, RA Harle, P Tucker, et al. (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131 699-702.
139. RJ Croughs, HA Hulsmans, DE Israel, et al. (1972) Glucagonoma as part of the polyglandular adenoma syndrome. Am J Med 52 690-698.
140. A Tiengo, D Fedele, E Marchiori, et al. (1975) Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin. Diabetes 25 408-412.
141. J Leclere, F Vicari, J Laurent, et al. (1977) Islet cell tumor with diarrhea and diabetes (glucagonoma?) associated with hyperparathyroidism: Long-term results of local-regional treatment with streptozotocin. Ann Endocrinol (Paris) 38 153-154.
142. PW Stacpoole, J Jaspan, AG Kasselberg, et al. (1981) A familial glucagonoma syndrome: Genetic, clinical and biochemical features. Am J Med 70 1017-1026.
143. JH Bassett (1997) Glucagonomas in multiple endocrine neoplasia type 1. J Endocrinol 152 68.
144. GM Strauss, SA Weitzman and TT Aoki (1979) Dimethyltriazenoimidazole carboxamide therapy of malignant glucagonoma. Ann Intern Med 90 57-58.
145. SP Marynick, WR Fagadau and LA Duncan (1980) Malignant glucagonoma syndrome: Response to chemotherapy. Ann Intern Med 93 453-454.
146. JV Verner and AB Morrison (1958) Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 25 374-380.
147. IN Marks, S Bank and JH Louw (1967) Islet cell tumor of the pancreas with reversible watery diarrhea and achlorhydria. Gastroenterology 52 695-708.
148. SR Bloom, JM Polak and AG Pearse (1973) Vasoactive intestinal peptide and watery diarrhoea syndrome. Lancet 2 14-16.
149. CH Brown and G Crile Jr (1964) Pancreatic adenoma with intractable diarrhea, hypokalemia, and hypercalcemia. JAMA 190 30-34.
150. A Burkhardt (1976) The Verner-Morrison syndrome: the clinical picture and pathologic anatomy. Klin Wochenschr 54 1-11.
151. RG Long, AJ Barnes, TE Adrian, et al. (1979) Suppression of pancreatic endocrine tumor secretion by long-acting somatostatin analogue. Lancet 2 764-767.
152. CR Kahn, AG Levy, JD Gardner, et al. (1975) Pancreatic cholera: Beneficial effects of treatment with streptozotocin. N Engl J Med 292 941-945.
153. JG Kingham, R Dick, SR Bloom, et al. (1978) Vipoma: Localisation by percutaneous transhepatic portal venous sampling. Br Med J 2 1682-1683.
154. BM Jaffe, DF Kopen, K DeSchryver-Kecskemeti, et al. (1977) Indomethacin-responsive pancreatic cholera. N Engl J Med 297 817-821.
155. RG Long, MG Bryant, PM Yuille, et al. (1981) Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: Improvement of diarrhoea with metoclopramide. Gut 22 505-511.
156. SJ Pandol, LY Korman, DM McCarthy, et al. (1980) Beneficial effect of oral lithium carbonate in the treatment of pancreatic cholera syndrome. N Engl J Med 302 1403-1404.
157. SR Friesen, JR Kimmel and T Tomita (1980) Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies. Am J Surg 139 61-72.
158. B Skogseid, K Oberg, L Benson, et al. (1987) A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. J Clin Endocrinol Metab 64 1233-1240.
159. CB Lamers and CM Diemel (1982) Basal and postatropine serum pancreatic polypeptide concentrations in familial multiple endocrine neoplasia type I. J Clin Endocrinol Metab 55 774-778.
160. H Takahashi, K Nakano, Y Adachi, et al. (1988) Multiple nonfunctional pancreatic islet cell tumor in multiple endocrine neoplasia type I: a case report. Acta Pathol Jpn 38 667-682.
161. SR Bloom, JM Polak and AM West (1978) Somatostatin content of pancreatic endocrine tumors. Metabolism 27(9 Suppl 1), 1235-1238.
162. R Guillemin (1978) Some thoughts on current research with somatostatin. Metabolism 27(9 Suppl 1), 1453-1461.
163. K Lundbaek (1978) Somatostatin: Clinical importance and outlook. Metabolism 27(9 Suppl 1), 1463-1469.
164. GJ Krejs, L Orci, JM Conlon, et al. (1979) Somatostatinoma syndrome: Biochemical, morphologic and clinical features. N Engl J Med 301 285-292.
165. J Soga and Y Yakuwa (1999) Somatostatinoma/inhibitory syndrome: A statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 18 13-22.
166. SL Asa, W Singer, K Kovacs, et al. (1987) Pancreatic endocrine tumor producing growth hormone-releasing hormone associated with multiple endocrine neoplasia type I syndrome. Acta Endocrinol (Copenh) 115 331-337.
167. T Sano, R Yamasaki, H Saito, et al. (1987) Growth hormone-releasing hormone (GHRH)-secreting pancreatic tumor in a patient with multiple endocrine neoplasia type I. Am J Surg Pathol 11 810-819.
168. T Sano, SL Asa and K Kovacs (1988) Growth hormone-releasing hormone-producing tumors: Clinical, biochemical, and morphological manifestations. Endocr Rev 9 357-373.
169. PR Prosser, JH Karam, JJ Townsend, et al. (1979) Prolactin-secreting pituitary adenomas in multiple endocrine adenomatosis, type I. Ann Intern Med 91 41-44.
170. NR Farid, S Buehler, NA Russell, et al. (1980) Prolactinomas in familial multiple endocrine neoplasia syndrome type I: Relationship to HLA and carcinoid tumors. Am J Med 69 874-880.
171. PN Maton, JD Gardner and RT Jensen (1986) Cushing's syndrome in patients with the Zollinger-Ellison syndrome. N Engl J Med 315 1-5.
172. D Gaitan, PT Loosen and DN Orth (1993) Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I. J Clin Endocrinol Metab 76 1580-1582.
173. KS Hershon, WA Kelly, CM Shaw, et al. (1983) Prolactinomas as part of the multiple endocrine neoplastic syndrome type 1. Am J Med 74 713-720.
174. JM Bidart, E Baudin, F Troalen, et al. (1997) Eutopic and ectopic production of glycoprotein hormones alpha and beta subunits. Ann Endocrinol (Paris) 58 125-128.
175. J Trouillas, F Labat-Moleur, N Sturm, et al. (2008) Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol 32 534-543.
176. QY Duh, CP Hybarger, R Geist, et al. (1987) Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154 142-148.
177. ED Williams and LR Celestin (1963) The association of bronchial carcinoid and pluriglandular adenomatosis. Thorax 17 120-127.
178. ER Fisher and J Hicks (1960) Further pathologic observations on the syndrome of peptic ulcer and multiple endocrine tumors. Gastroenterology 38 458-466.
179. N Snyder 3rd, MT Scurry and WP Deiss (1972) Five families with multiple endocrine adenomatosis. Ann Intern Med 76 53-58.
180. J Rode, AP Dhillon, PB Cotton, et al. (1987) Carcinoid tumor of stomach and primary hyperparathyroidism: A new association. J Clin Pathol 40 546-551.
181. G Cadiot, P Laurent-Puig, B Thuille, et al. (1993) Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology 105 579-582.
182. C Lee (1980) Carcinoid tumor of the pancreas causing the diarrheogenic syndrome: Report of a case combined with multiple endocrine neoplasia type 1. Surgery 99 123-129.
183. BT Teh, J McArdle, SP Chan, et al. (1997) Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine (Baltimore) 76 21-29.
184. BT Teh, J Zedenius, S Kytola, et al. (1998) Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 228 99-105.
185. C Bordi, A Falchetti, C Azzoni, et al. (1997) Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol 21 1075-1082.
186. C Bordi, T D'Adda, C Azzoni, et al. (1998) Pathogenesis of ECL cell tumors in humans. Yale J Biol Med 71 273-284.
187. F Gibril, JC Reynolds, IA Lubensky, et al. (2000) Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: A prospective study. J Nucl Med 41 1646-1656.
188. G Rindi (1996) Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology and behaviour: Clinicopathologic analysis of 205 cases. World J Surg 20 158-172.
189. MJ Berna, B Annibale, M Marignani, et al. (2008) A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab 93 1582-1591.
190. P Tomassetti, M Migliori, GC Caletti, et al. (2000) Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 343 551-554.
191. B Skogseid, C Larsson, PG Lindgren, et al. (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75 76-81.
192. B Skogseid, J Rastad, A Gobl, et al. (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118 1077-1082.
193. S Schaefer, M Shipotko, S Meyer, et al. (2008) Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Eur J Endocrinol 158 699-704.
194. JW Raker, PH Hanneman and WS Graf (1962) Coexisting primary hyperparathyroidism and Cushing's syndrome. J Clin Endocrinol Metab 22 273-280.
195. RG Dluhy and GH Williams (1969) Primary aldosteronism in a hypertensive acromegalic patient. J Clin Endocrinol Metab 29 1319-1324.
196. A Fertig, M Webley and JA Lynn (1980) Primary hyperparathyroidism in a patient with Conn's syndrome. Postgrad Med J 56 45-47.
197. A Beckers, R Abs, PJ Willems, et al. (1992) Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab 75 564-570.
198. TN Darling, MC Skarulis, SM Steinberg, et al. (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 133 853-857.
199. A Vidal, MJ Iglesias, B Fernández, et al. (2008) Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1. J Eur Acad Dermatol Venereol 22 835-838.
200. EB Ilgren and D Westmoreland (1984) Tuberous sclerosis: Unusual associations in four cases. J Clin Pathol 37 272-278.
201. B Vogelstein and KW Kinzler (1993) The multistep nature of cancer. Trends Genet 9 138-141.
202. MA Brown and E Solomon (1997) Studies on inherited cancers: Outcomes and challenges of 25 years. Trends Genet 13 202-206.
203. KW Kinzler and B Vogelstein (1997) Cancer-susceptibility genes: Gatekeepers and caretakers. Nature 386 761-763.
204. A de Klein, AG van Kessel, G Grosveld, et al. (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300 765-767.
205. R Kurzrock, JU Gutterman and M Talpaz (1988) The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319 990-998.
206. R Dalla-Favera, M Bregni, J Erikson, et al. (1982) Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79 7824-7837.
207. MF Hansen and WK Cavenee (1988) Retinoblastoma and the progression of tumor genetics. Trends Genet 4 125-128.
208. AG Knudson Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68 820-823.
209. AG Knudson Jr, LC Strong and DE Anderson (1973) Heredity and cancer in man. Prog Med Genet 9 113-158.
210. C Bystrom, C Larsson, C Blomberg, et al. (1990) Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci U S A 87 1968-1972.
211. RV Thakker, MA Pook, C Wooding, et al. (1993) Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91 2815-2821.
212. The European Consortium on MEN1 (1997) Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. Genomics 44 94-100.
213. LV Debelenko, MR Emmert-Buck, P Manickam, et al. (1997) Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res 57 1039-1042.
214. B Zablewska, L Bylund, SA Mandic, et al. (2003) Transcription regulation of the multiple endocrine neoplasia type 1 gene in human and mouse. J Clin Endocrinol Metab 88 3845-3851.
215. M Fromaget, C Vercherat, CX Zhang, et al. (2003) Functional characterization of a promoter region in the human MEN1 tumor suppressor gene. J Mol Biol 333 87-102.
216. S Khodaei-O'Brien, B Zablewska, M Fromaget, et al. (2000) Heterogeneity at the 5′ end of MEN1 transcripts. Biochem Biophys Res Commun 276 508-514.
217. MC Lemos and RV Thakker (2008) Multiple endocrine neoplasia type 1 (MEN1): Analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29 22-32.
218. SC Guru, PK Goldsmith, AL Burns, et al. (1998) Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A 95 1630-1644.
219. SK Agarwal, MB Kester, LV Debelenko, et al. (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 6 1169-1175.
220. LV Debelenko, E Brambilla, SK Agarwal, et al. (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6 2285-2290.
221. BT Teh, S Kytola, F Farnebo, et al. (1998) Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 83 2621-2626.
222. JJ Turner, PD Leotlela, AA Pannett, et al. (2002) Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 87 2688-2693.
223. T Abe, K Yoshimoto, M Taniyama, et al. (2000) An unusual kindred of the multiple endocrine neoplasia type 1 (MEN1) in Japanese. J Clin Endocrinol Metab 85 1327-1330.
224. BM Cavaco, R Domingues, MC Bacelar, et al. (2002) Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clin Endocrinol (Oxf) 56 465-473.
225. AA Pannett and RV Thakker (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson “two-hit” hypothesis. J Clin Endocrinol Metab 86 4371-4374.
226. C Heppner, MB Kester, SK Agarwal, et al. (1997) Somatic mutation of the MEN1 gene in parathyroid tumors. Nat Genet 16 375-378.
227. T Carling (1998) Parathyroid MEN1 gene mutations in relation to clinical characteristics of non-familial primary hyperparathyroidism. J Clin Endocrinol Metab 83 2951-2954.
228. F Farnebo, BT Teh, S Kytola, et al. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 838 2627-2630.
229. L Shan, Y Nakamura, M Nakamura, et al. (1998) Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Lab Invest 78 471-475.
230. L Ludwig, L Schleithoff, H Kessler, et al. (1999) Loss of wild-type MEN1 gene expression in multiple endocrine neoplasia type 1–associated parathyroid adenoma. Endocr J 46 539-544.
231. EH Wang, SA Ebrahimi, AY Wu, et al. (1998) Mutation of the menin gene in sporadic pancreatic endocrine tumors. Cancer Res 58 4417-4420.
232. Z Zhuang, AO Vortmeyer, S Pack, et al. (1997) Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57 4682-4686.
233. K Cupisti, W Hoppner, C Dotzenrath, et al. (2000) Lack of MEN1 gene mutations in 27 sporadic insulinomas. Eur J Clin Invest 30 325-329.
234. MD Mailman, P Muscarella, WJ Schirmer, et al. (1999) Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue. Clin Chem 45 29-34.
235. O Hessman, D Lindberg, B Skogseid, et al. (1998) Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res 58 377-379.
236. TR Prezant, J Levine and S Melmed (1998) Molecular characterization of the MEN1 tumor suppressor gene in sporadic pituitary tumors. J Clin Endocrinol Metab 83 1388-1391.
237. R Boni, AO Vortmeyer, S Pack, et al. (1988) Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. J Invest Dermatol 111 539-540.
238. AO Vortmeyer, R Boni, E Pak, et al. (1998) Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas. J Natl Cancer Inst 90 398-399.
239. AA Pannett (1999) Meta-analysis of 31 studies reporting 344 mutations in the multiple endocrine neoplasia type 1 (MEN1) gene [Abstract]. J Bone Miner Res 14 S321.
240. CA Landis, SB Masters, A Spada, et al. (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 340 692-696.
241. J Lyons, CA Landis, G Harsh, et al. (1990) Two G protein oncogenes in human endocrine tumors. Science 249 655-659.
242. RV Thakker (1996) Molecular genetics of parathyroid disease, Endocrinol. Diabetes 3 521-528.
243. FM Hannan, MA Nesbit, PT Christie, et al. (2008) Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene. Nat Clin Pract Endocrinol Metab 4 53-58.
244. Gadelha MR, Une KN, Vaisman M, et al: Localization of the isolated familial somatotropinoma gene to a 7.4 Mb region at chromosome 11q13 by allelotype and haplotype analyses [abstract]. In Proceedings of the Endocrine Society's 81st Annual Meeting, June 12–15, 1999, San Diego, CA.
245. SE Olufemi, JS Green, P Manickam, et al. (1998) Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Hum Mutat 11 264-269.
246. W Hao, MC Skarulis, WF Simonds, et al. (2004) Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. J Clin Endocrinol Metab 89 3776-3784.
247. JR Burgess, B Nord, R David, et al. (2000) Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN1). Clin Endocrinol (Oxf) 53 205-211.
248. BS Soares and LA Frohman (2004) Isolated familial somatotropinoma. Pituitary 7 95-101.
249. BS Soares, K Eguchi and LA Frohman (2005) Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas. J Clin Endocrinol Metab 90 6580-6587.
250. O Vierimaa, M Georgitsi, R Lehtonen, et al. (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 1228-1230.
251. A Karhu and LA Aaltonen (2007) Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. Hum Mol Genet 16 R73-R79.
252. S Igreja, H Chahal, S Akker, et al. (2008) Menin-mutation negative MEN1-syndrome patients have no germline p27 (cyclin-dependent kinase inhibitor 1B) or AIP1 aryl hydrocarbon receptor–interacting protein / mutations. Endocr Abstracts 15 P169.
253. P La, A Desmond, Z Hou, et al. (2006) Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression. Oncogene 25 3537-3546.
254. SC Huang, Z Zhuang, RJ Weil, et al. (1999) Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Lab Invest 79 301-310.
255. SK Agarwal, A Lee Burns, KE Sukhodolets, et al. (2004) Molecular pathology of the MEN1 gene. Ann N Y Acad Sci 1014 189-198.
256. A Poisson, B Zablewska and P Gaudray (2003) Menin interacting proteins as clues toward the understanding of multiple 279:40267–40275 endocrine neoplasia type 1. Cancer Lett 189 1-10.
257. W Yumita, Y Ikeo, K Yamauchi, et al. (2003) Suppression of insulin-induced AP-1 transactivation by menin accompanies inhibition of c-Fos induction. Int J Cancer 103 738-744.
258. C Heppner, KY Bilimoria, SK Agarwal, et al. (2001) The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 20 4917-4925.
259. H Kaji, L Canaff, JJ Lebrun, et al. (2001) Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc Natl Acad Sci U S A 98 3837-3842.
260. H Sowa, H Kaji, L Canaff, et al. (2003) Inactivation of menin, the product of multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. J Biol Chem 23 21058-21069.
261. IH Lemmens, L Forsberg, AA Pannett, et al. (2001) Menin interacts directly with the homeobox-containing protein Pem. Biochem Biophys Res Commun 286 426-431.
262. H Kim, JE Lee, EJ Cho, et al. (2003) Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res 63 6135-6139.
263. V Busygina, MC Kottemann, KL Scott, et al. (2006) Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response. Cancer Res 66 8397-8403.
264. A Gallo, C Cuozzo, I Esposito, et al. (2002) Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation. Oncogene 21 6434-6445.
265. W Yumita, Y Ikeo, K Yamauchi, et al. (2003) Suppression of insulin-induced AP-1 transactivation by menin accompanies inhibition of c-Fos induction. Int J Cancer 103 738-744.
266. CM Hughes, O Rozenblatt-Rosen, TA Milne, et al. (2004) Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13 587-597.
267. A Yokoyama and ML Cleary (2008) Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14 36-46.
268. L Roudaia and NA Speck (2008) A MENage à trois in leukemia. Cancer Cell 14 3-5.
269. A Yokoyama, Z Wang, J Wysocka, et al. (2004) Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24 5639-5649.
270. SK Karnik, CM Hughes, X Gu, et al. (2005) Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci U S A 102 14659-14664.
271. TA Milne, CM Hughes, R Lloyd, et al. (2005) Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A 102 749-754.
272. HC Shen, JE Rosen, LM Yang, et al. (2008) Parathyroid tumor development involves deregulation of homeobox genes. Endocr Relat Cancer 15 267-275.
273. KM Dreijerink, KW Mulder, GS Winkler, et al. (2006) Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res 66 4929-4935.
274. PC Scacheri, S Davis, DT Odom, et al. (2006) Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet 2 e51.
275. P La, AC Silva, Z Hou, et al. (2004) Direct binding of DNA by tumor suppressor menin. J Biol Chem 279 49045-49054.
276. P La, Y Yang, SK Karnik, et al. (2007) Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1. J Biol Chem 26 31332-31340.
277. AW Mould, R Duncan, M Serewko-Auret, et al. (2007) Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling. Int J Cancer 15 776-783.
278. KE Sukhodolets, AB Hickman, SK Agarwal, et al. (2003) The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol Cell Biol 23 493-509.
279. N Ohkura, M Kishi, T Tsukada, et al. (2001) Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23. Biochem Biophys Res Commun 282 1206-1210.
280. H Yaguchi, N Ohkura, T Tsukada, et al. (2002) Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J Biol Chem 277 38197-38204.
281. VH Obungu, A Lee Burns, SK Agarwal, et al. (2003) Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain. Oncogene 22 6347-6358.
282. SI Hirai, RP Ryseck, F Mechta, et al. (1989) Characterization of JunD: A new member of the Jun proto-oncogene family. EMBO J 8 1433-1439.
283. K Ryder, A Lanahan, E Perez-Albuerne, et al. (1989) Jun D, a third member of the Jun gene family. Proc Natl Acad Sci U S A 86 1500-1503.
284. CM Pfarr, F Mechta, G Spyrou, et al. (1994) Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76 747-760.
285. H Sowa, H Kaji, GN Hendy, et al. (2004) Menin is required for BMP-2- and TGF-beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem 279 40267-40275.
286. S Jin, H Mao, RW Schnepp, et al. (2003) Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res 63 4204-4210.
287. J Lopez-Egido, J Cunningham, M Berg, et al. (2002) Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity. Exp Cell Res 278 175-183.
288. RW Schnepp, Z Hou, H Wang, et al. (2004) Functional interaction between tumor suppressor menin and activator of S-phase kinase. Cancer Res 64 6791-6796.
289. SY Lin and SJ Elledge (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 881-889.
290. P Stalberg, P Grimfjard, M Santesson, et al. (2004) Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1. J Clin Endocrinol Metab 89 2326-2337.
291. YS Kim, AL Burns, PK Goldsmith, et al. (1999) Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18 5936-5942.
292. N Hussein, H Casse, S Fontaniere, et al. (2007) Reconstituted expression of menin in Men1-deficient mouse Leydig tumor cells induces cell cycle arrest and apoptosis. Eur J Cancer 43 402-414.
293. JA Holbrook, G Neu-Yilik, MW Hentze, et al. (2004) Nonsense-mediated decay approaches the clinic. Nat Genet 36 801-808.
294. M Khajavi, K Inoue and JR Lupski (2006) Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14 1074-1081.
295. M Khajavi, K Inoue and JR Lupski (2006) Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14 1074-1081.
296. F Pagani and FE Baralle (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5 389-396.
297. D Baralle and M Baralle (2005) Splicing in action: assessing disease causing sequence changes. J Med Genet 42 737-748.
298. MC Lemos, B Harding, SM Shalet, et al. (2007) A novel MEN1 intronic mutation associated with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 66 709-713.
299. H Yaguchi, N Ohkura, M Takahashi, et al. (2004) Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol Cell Biol 24 6569-6580.
300. C Stewart, F Parente, F Piehl, et al. (1998) Characterization of the mouse Men1 gene and its expression during development. Oncogene 17 2485-2493.
301. JH Bassett, P Rashbass, B Harding, et al. (1999) Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, men1. J Bone Miner Res 14 3-10.
302. JS Crabtree, PC Scacheri, JM Ward, et al. (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A 98 1118-1123.
303. P Bertolino, WM Tong, D Galendo, et al. (2003) Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol 17 1880-1892.
304. KA Loffler, CA Biondi, M Gartside, et al. (2007) Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. Int J Cancer 120 259-267.
305. MC Lemos, B Harding, M Bowl, et al. (2007) Mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele develop pancreatic, pituitary and parathyroid tumors in association with hypercalcemia. Endocr Abstracts 13 OC22.
306. PC Scacheri, JS Crabtree, EA Novotny, et al. (2001) Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 30 259-263.
307. P Bertolino, I Radovanovic, H Casse, et al. (2003) Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mech Dev 120 549-560.
308. KA Engleka, M Wu, M Zhang, et al. (2007) Menin is required in cranial neural crest for palatogenesis and perinatal viability. Dev Biol 311 524-537.
309. F Bai, XH Pei, T Nishikawa, et al. (2007) p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors. Mol Cell Biol 27 1495-1504.
310. A Fritz, A Walch, K Piotrowska, et al. (2002) Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Res 62 3048-3051.
311. K Piotrowska, NS Pellegata, M Rosemann, et al. (2004) Mapping of a novel MEN-like syndrome locus to rat chromosome 4. Mamm Genome 15 135-141.
312. NS Pellegata, L Quintanilla-Martinez, H Siggelkow, et al. (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 17 15558-15563.
313. M Georgitsi, A Raitila, A Karhu, et al. (2007) Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92 3321-3325.
314. A Ozawa, SK Agarwal, CM Mateo, et al. (2007) The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. J Clin Endocrinol Metab 92 1948-1951.
315. K Frank-Raue, S Rondot, W Hoeppner, et al. (2005) Coincidence of multiple endocrine neoplasia types 1 and 2:mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism. J Clin Endocrinol Metab 90 4063-4067.
316. ML Brandi, GD Aurbach, LA Fitzpatrick, et al. (1986) Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med 314 1287-1293.
317. MB Zimering, ML Brandi, DA deGrange, et al. (1990) Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 70 149-154.
318. SJ Bale, AE Bale, K Stewart, et al. (1989) Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11. Genomics 4 320-322.
319. JT Pang, SE Lloyd, C Wooding, et al. (1996) Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene. Hum Genet 97 732-741.
320. SJ Marx, K Sakaguchi, J Green 3rd, et al. (1988) Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 67 149-153.
321. MB Zimering, N Katsumata, Y Sato, et al. (1993) Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: Relation to pituitary tumor. J Clin Endocrinol Metab 76 1182-1187.
322. C Larsson, J Shepherd, Y Nakamura, et al. (1992) Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest 89 1344-1349.
323. American Society of Human Genetics Board of Directors American College of Medical Genetics Board of Directors (1995) Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 57 1233-1241.
324. E Tham, U Grandell, E Lindgren, et al. (2007) Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J Clin Endocrinol Metab 92 3389-3395.
325. A Machens, L Schaaf, W Karges, et al. (2007) Age-related penetrance of endocrine tumors in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers. Clin Endocrinol (Oxf) 67 613-622.
326. CR Pieterman, JM Schreinemakes, HP Koppeschaar, et al. (2009) Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Clin Endocrinol (Oxf) 70 575-581.
327. B Skogseid, B Eriksson, G Lundqvist, et al. (1991) Multiple endocrine neoplasia type 1: A 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73 281-287.
328. A Scarsbrook, RV Thakker, JAH Wass, et al. (2006) Multiple Endocrine Neoplasia: spectrum of radiologic appearances and discussion of a multi-technique imaging approach. Radiographics 26 433-451.